Compound shows promise for minimizing erratic movements in Parkinson’s patients — ScienceDaily

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson’s disease.

Click here to view the original article.